Has Stanley Thompson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $466,386 in general payments to Stanley Thompson, MD across 413 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stanley Thompson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stanley Thompson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stanley Thompson, MD

Emergency Medicine · Southaven, MSNPI 1740221365

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $292,980 of the $466,386 with a category attached, or 62.8%. Johnson & Johnson accounts for 83.8% of it on its own, with 2 other manufacturers making up the rest. Among emergency medicine clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$466,386in general payments, 2019–2025

Across 413 payments — averaging $1129.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$391K
Janssen Scientific Affairs, LLC$66K
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$9K

What the payments were for

Consulting fees$117,60325%
Speaking & faculty fees$292,98063%
Travel & lodging$46,78910%
Food & beverage$9,0142%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	352	$390,692
Janssen Scientific Affairs, LLC	52	$66,469
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	9	$9,225

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XARELTO$419,500
XIFAXAN$5,625
RELISTOR$3,600
LUCEMYRA$1,200

How this compares

$466,386 in reported general payments places this provider in the 95th percentile of 443 emergency medicine providers in Mississippi.

See all emergency medicine providers in Mississippi →

Medicare billing

Part B allowed, 2024

$11,440

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Naproxen	14	$73

Paid to pharmacies, not to this prescriber.

Other emergency medicine in Southaven

Kenneth ThompsonSouthaven$1K
Alexander MeyerSouthaven$767
Adam CumminsSouthaven$531
Utsav NandiJackson$54K
Richard SummersJackson$20K
Damon DarseyJackson$11K
Kenneth WhittingtonHazlehurst$8K
Samuel Richardson IiiJackson$8K
Joseph PongettiJackson$5K
Robert WalkerHazlehurst$5K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →